MedPath

the effectiveness of self care management support intervention on medication adherence pruritus severity, sleep quality and quality of life in patients with chronic kidney disease associated pruritus

Phase 4
Conditions
Health Condition 1: null- Chronic Kidney Disease associated Pruritus
Registration Number
CTRI/2016/04/006870
Lead Sponsor
Institutional Review Board CMC Vellore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
210
Inclusion Criteria

1.Have mild, moderate and severe pruritus.

2.Are expected to continue treatment as out patient

3.Can read and comprehend Tamil, English, and Hindi.

4.Give consent to participate in the study.

Exclusion Criteria

1.Are with cognitive, hearing and speech disabilities.

2.Are with serious illness and unable to follow the instructions.

3.Are undergoing hemodialysis.

4.Has history of dermatologic diseases such as psoriasis, various form of dermatitis, lichen simplex and dermatophytosis.

5.Are unwilling to comply with the study protocol, mode of administration and duration of treatment.

6.Are becoming sick during the study period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase in medication adherence, Reduction of pruritus severity, Increase in sleep quality and Improve in quality of life in patients with chronic kidney disease associated pruritus.Timepoint: 30th day, 60th day and 90th day
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath